Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Percutaneous Coronary Intervention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04774913
What this trial is testing

Invest-CTO PCI Trial

Who this might be right for
Chronic Total Occlusion of Coronary ArteryAngina PectorisQuality of Life+1 more
Haukeland University Hospital 200
Not applicableLooking for participantsNCT07009418
What this trial is testing

Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)

Who this might be right for
Ischemic Heart DiseaseCoronary Artery Disease
Samsung Medical Center 3,500
Post-approval studies (Phase 4)Study completedNCT02096419
What this trial is testing

Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity

Who this might be right for
Acute Coronary Syndrome
University of Zagreb 87
Large-scale testing (Phase 3)Study completedNCT00345501
What this trial is testing

Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention

Who this might be right for
Renal Insufficiency, ChronicCoronary AngiographyAngioplasty, Transluminal, Percutaneous Coronary
Onassis Cardiac Surgery Centre 208
Not applicableActive Not RecruitingNCT07622446
What this trial is testing

Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).

Who this might be right for
High-risk PCI
Shanghai Dynaheart Medtech Co., Ltd. 254
Not applicableActive Not RecruitingNCT07010965
What this trial is testing

SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI

Who this might be right for
High-Risk PCI
magAssist, Inc. 236
Not applicableLooking for participantsNCT06274411
What this trial is testing

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

Who this might be right for
ECMOHigh-risk PCI
Beijing Anzhen Hospital 176
Not applicableStudy completedNCT05727059
What this trial is testing

Magenta Elevate™ EFS in High-Risk PCI Patients

Who this might be right for
High-risk Percutaneous Coronary Intervention
Magenta Medical Ltd. 18
Not applicableStudy completedNCT06853470
What this trial is testing

Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial

Who this might be right for
High Risk PCICoronary Arterial Disease (CAD)
ForQaly Medical (Shanghai) Co., Ltd 222
Not applicableUnknownNCT02806102
What this trial is testing

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Who this might be right for
Acute Myocardial InfarctionPercutaneous Coronary InterventionMajor Adverse Cardiovascular Events+1 more
Seoul St. Mary's Hospital 13,000
Post-approval studies (Phase 4)Study completedNCT03465644
What this trial is testing

TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

Who this might be right for
Coronary Stenoses
Duk-Woo Park, MD 2,018
Post-approval studies (Phase 4)Study completedNCT01012193
What this trial is testing

Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary Intervention
Gyeongsang National University Hospital 134
Not applicableUnknownNCT04151680
What this trial is testing

Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients

Who this might be right for
Ischemic Heart DiseaseAtrial Fibrillation
University of Roma La Sapienza 100
Not applicableActive Not RecruitingNCT05221931
What this trial is testing

Drug-Coated Balloon in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 1,359
Post-approval studies (Phase 4)Ended earlyNCT02601664
What this trial is testing

Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions

Who this might be right for
ArteriosclerosisNear-infrared SpectroscopyPeri-procedural Myocardial Infarction+1 more
North Texas Veterans Healthcare System 3
Not applicableUnknownNCT05554588
What this trial is testing

Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI

Who this might be right for
Acute Coronary SyndromeST Elevation Myocardial InfarctionPercutaneous Coronary Intervention
China-Japan Friendship Hospital 2,500
Not applicableNot Yet RecruitingNCT07557238
What this trial is testing

CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China

Who this might be right for
Coronary Artery DiseaseHigh Risk PCIPercutaneous Coronary Intervention (PCI)
Guofeng Gao 1,000
Not applicableStudy completedNCT04854070
What this trial is testing

Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures

Who this might be right for
Complex Coronary Lesions
ECRI bv 2,020
Not applicableLooking for participantsNCT07053618
What this trial is testing

Interventional Left Ventricular Assist System for PCI in CHIP Patients

Who this might be right for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD 286
Post-approval studies (Phase 4)UnknownNCT03112707
What this trial is testing

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

Who this might be right for
Coronary Artery DiseaseAcute Coronary Syndrome
Humanitas Hospital, Italy 1,023
Next Page